Insulet Corporation
137.92USD
-4.3600 (-3.06%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 1.1B | 1.7B | 2.1B | 2.7B | 3.3B | 3.7B |
| Q1 | 247.0M | 261.3M | 441.7M | 569.0M | 761.7M | — |
| Q2 | 243.9M | 396.5M | 488.5M | 649.1M | 801.7M | — |
| Q3 | 281.9M | 432.7M | 543.9M | 706.3M | 833.2M | — |
| Q4 | 282.6M* | 509.8M* | 597.5M* | 783.8M* | 894.2M | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | .070 | 2.94 | 5.78 | 3.48 | 6.50 | 7.71 |
| Q1 | .400 | .340 | .730 | .500 | 1.30 | — |
| Q2 | -.500 | .390 | 2.59 | .320 | 1.37 | — |
| Q3 | -.080 | .740 | 1.08 | 1.24 | 1.59 | — |
| Q4 | .243* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| 1.40* |
| 1.36* |
| 1.41* |
| 1.84 |
| — |